Literature DB >> 10517897

Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis.

M Voutilainen1, M Färkkilä, M Juhola, J P Mecklin, P Sipponen.   

Abstract

BACKGROUND/AIMS: Intestinal metaplasia (IM) is a common finding at the oesophagogastric junction, but the aetiopathogenesis of the different IM subtypes-that is, incomplete IM (specialised columnar epithelium, SCE) and complete IM- and their associations with gastro-oesophageal reflux disease and Helicobacter pylori gastritis are unclear.
METHODS: 1058 consecutive dyspeptic patients undergoing gastroscopy were enrolled. The gastric, oesophagogastric junctional, and oesophageal biopsy specimens obtained were stained with haematoxylin and eosin, alcian blue (pH 2.5)-periodic acid Schiff, and modified Giemsa.
RESULTS: Complete junctional IM was detected in 196 (19%) of the 1058 subjects, and in 134 (13%) was the sole IM subtype. Incomplete junctional IM (SCE) was detected in 101 (10%) subjects, of whom 62 (61%) also had the complete IM subtype. Of patients with normal gastric histology (n = 426), 6% had complete IM and 7% junctional SCE. The prevalence of both types of IM increased with age in patients with either normal gastric histology or chronic gastritis (n = 611). Epithelial dysplasia was not detected in any patients with junctional IM. In multivariate analysis, independent risk factors for incomplete junctional IM were age (odds ratio (OR) 1.3 per decade, 95% confidence interval (CI) 1.2 to 1.6), endoscopic erosive oesophagitis (OR 1.9, 95% CI 1.1 to 3.2), and chronic cardia inflammation (OR 2.9, 95% CI 1.3 to 6.2), but not gastric H pylori infection (OR 1.0, 95% CI 0.6 to 1.7). In univariate analysis, junctional incomplete IM was not associated with cardia H pylori infection. Independent risk factors for "pure" complete junctional IM (n = 134) were age (OR 1.2 per decade, 95% CI 1.0 to 1.4), antral predominant non-atrophic gastritis (OR 2.6, 95% CI 1.3 to 5.2), antral predominant atrophic gastritis (OR 2.1, 95% CI 1.1 to 5.2), and multifocal atrophic gastritis (OR 7.1, 95% CI 2.5 to 19.8). In univariate analysis, junctional complete IM was strongly associated with chronic cardia inflammation and cardia H pylori infection (p<0. 001).
CONCLUSIONS: Both complete and incomplete junctional IM are independent acquired lesions that increase in prevalence with age. Although IM subtypes often occur simultaneously, they show remarkable differences in their associations with gastritis and erosive oesophagitis: junctional complete IM is a manifestation of multifocal atrophic gastritis, while the incomplete form (SCE) may result from carditis and gastro-oesophageal reflux disease. The frequency of dysplasia in intestinal metaplasia at the oesophagogastric junction appears to be low.

Entities:  

Mesh:

Year:  1999        PMID: 10517897      PMCID: PMC1727727          DOI: 10.1136/gut.45.5.644

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

Review 1.  The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.

Authors:  R H Riddell
Journal:  Am J Surg Pathol       Date:  1996       Impact factor: 6.394

Review 2.  The Sydney System: histological division.

Authors:  A B Price
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

Review 3.  The spectrum of columnar-lined esophagus--Barrett's esophagus.

Authors:  G N Tytgat; W Hameeteman; R Onstenk; R Schotborg
Journal:  Endoscopy       Date:  1989-07       Impact factor: 10.093

4.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion.

Authors:  S A McClave; H W Boyce; M R Gottfried
Journal:  Gastrointest Endosc       Date:  1987-12       Impact factor: 9.427

Review 5.  A human model of gastric carcinogenesis.

Authors:  P Correa
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

6.  Normal histology of the stomach.

Authors:  D A Owen
Journal:  Am J Surg Pathol       Date:  1986-01       Impact factor: 6.394

7.  Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus).

Authors:  M R Gottfried; S A McClave; H W Boyce
Journal:  Am J Clin Pathol       Date:  1989-12       Impact factor: 2.493

8.  Role of intestinal metaplasia in the histogenesis of gastric carcinoma.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

9.  Mucin histochemistry of intestinal metaplasia in Barrett's esophagus.

Authors:  H O Jauregui; K Davessar; J H Hale; N Kessimian; C Cenoz
Journal:  Mod Pathol       Date:  1988-05       Impact factor: 7.842

10.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Authors:  W J Blot; S S Devesa; R W Kneller; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

View more
  18 in total

Review 1.  Inflammation in the cardia.

Authors:  M Voutilainen; P Sipponen
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.

Authors:  Ying Chang; Bin Liu; Gui-Sheng Liu; Tao Wang; Jun Gong
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  Difference of gene expression profiles between Barrett's esophagus and cardia intestinal metaplasia by gene chip.

Authors:  Ying Chang; Bin Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

6.  Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

Authors:  M F Dixon; P M Neville; N P Mapstone; P Moayyedi; A T Axon
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

7.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 8.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

Review 9.  Barrett's esophagus: histopathologic definitions and diagnostic criteria.

Authors:  James Mueller; Martin Werner; Manfred Stolte
Journal:  World J Surg       Date:  2004-01-20       Impact factor: 3.352

10.  Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray.

Authors:  Ying Chang; Jun Gong; Bin Liu; Jun Zhang; Fei Dai
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.